Previous 10 | Next 10 |
The following slide deck was published by Agile Therapeutics, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Agile Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation
Agile Therapeutics, Inc. (AGRX) Q2 2021 Earnings Conference Call July 26, 2021, 4:30 PM ET Company Participants Matt Riley - Head, Investors Relations Al Altomari - Chairman and CEO Dennis Reilly - Chief Financial Officer Conference Call Participants Oren Livnat - H.C. Wainwright Tim Lugo - W...
Agile Therapeutics (AGRX): Q2 Non-GAAP EPS of -$0.21 beats by $0.01.Revenue of $1.2M (-14.3% Y/Y) misses by $0.33M.Shares +6.25%.Press Release For further details see: Agile Therapeutics EPS beats by $0.01, misses on revenue
Total Prescriptions (TRx) Grew 171% in Second Quarter Prescribers, New Prescriptions and Refill Rates Continue to Grow in Second Quarter Company Continues to Progress on Expanding Access to Twirla Management to Host Conference Call Today, Monday, July 26, 2021 at...
Shares of Agile Therapeutics Inc. (NASDAQ:AGRX) traded at a new 52-week low today of $1.09. This new low was reached on below average trading volume as 121,000 shares traded hands, while the average 30-day volume is approximately 1.1 million shares. In the past 52 weeks, Agile Therapeuti...
Shares of Agile Therapeutics Inc. (NASDAQ:AGRX) traded at a new 52-week low today of $1.16. This new low was reached on below average trading volume as 121,000 shares traded hands, while the average 30-day volume is approximately 1.1 million shares. Agile Therapeutics Inc is a women's he...
PRINCETON, N.J., July 01, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report second quarter 2021 financial results after the market close on Monday, July 26, 2021 as follows: Investors interes...
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the thr...
At the conclusion of the 2021 Russell indexes annual reconstitution following notable healthcare stocks will join the Russell 3000 Index, effective June 28 after the U.S. market opens.Bionano Genomics (BNGO), Asensus Surgical (ASXC), Ocugen (OCGN), Senseonics Holdings (SEN...
Vertex Energy (VTNR) +98% on deal for Shell's Mobile refinery.Moxian (MOXC) +37%.1847 Goedeker (GOED) +22%.SOS Limited (SOS) +14%.Bit Digital (BTBT) +13%.Vir Biotechnology (VIR) +9% as GSK/Vir COVID-19 biologic wins FDA Emergency Use Authorization.LAIX (LAIX) +12% on Q1 results...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
NASDAQ Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...